Outsourcing

Articles

CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.

CMC Biologics to Manufacture mAbs for the Treatment of Malaria

Catalent selects advisory board members to complement Redwood Bioscience Scientific Advisory Board.

Catalent Biologics Announces New Advisory Board

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

What if the expanding pipeline isn’t enough to fuel CMO growth?

What’s Next for the CMO Industry?

Agnes Shanley is senior editor of Pharmaceutical Technology.

Ignoring a contract partner’s ability to handle highly potent APIs (HPAPIs) safely may have serious consequences. Drug owners and contract service providers alike must understand the complexities and liabilities involved in working with HPAPIs.

Handling HPAPIs: Do Your CMOs Have the Right Stuff?

Within the past few years, key players have left the sterile manufacturing business. Can new technology and investment revitalize this critical market?

Industry Viewpoints: Can Sterile Manufacturing Turn the Ship Around?

While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.

CDMOs Cautiously Address Expansion

Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association speaks with Pharmaceutical Technology.

Pharma and Biopharma Outsourcing Association

Jim Miller, President of PharmSource, spoke with Pharmaceutical Technology about working with CMOs and CDMOs.

Working with CMOs and CDMOs

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The 12th Annual Report and Survey of Biomanufacturing is now available.

BioPlan Associates Releases 2015 Edition of its Annual Survey

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Contract Manufacturing Services